2seventy bio, Inc. (TSVT) Reports Q4 Loss, Tops Revenue Estimates

This article was originally published on Nasdaq

2seventy bio, Inc. (TSVT) came out with a quarterly loss of $0.60 per share versus the Zacks Consensus Estimate of a loss of $1.53. This compares to loss of $2.55 per share a year ago. These figures are adjusted for non-recurring items.